dc.contributor.author | Yalcin, Serap | |
dc.contributor.author | Unsoy, Gozde | |
dc.contributor.author | Mutlu, Pelin | |
dc.contributor.author | Khodadust, Rouhollah | |
dc.contributor.author | Gunduz, Ufuk | |
dc.date.accessioned | 2019-11-24T20:59:01Z | |
dc.date.available | 2019-11-24T20:59:01Z | |
dc.date.issued | 2014 | |
dc.identifier.issn | 1075-2765 | |
dc.identifier.issn | 1536-3686 | |
dc.identifier.uri | https://dx.doi.org/10.1097/MJT.0000000000000066 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12513/3202 | |
dc.description | WOS: 000345012600018 | en_US |
dc.description | PubMed ID: 25137407 | en_US |
dc.description.abstract | In this study, polyhydroxybutyrate (PHB)-coated magnetic nanoparticles (MNPs) were prepared by coprecipitation of iron salts (Fe2+ and Fe3+) by ammonium hydroxide. Characterizations of PHB-coated MNPs were performed by Fourier transform infrared spectroscopy, x-ray diffraction, dynamic light scattering, thermal gravimetric analysis, vibrating sample magnetometry, and transmission electron microscopy analyses. Doxorubicin was loaded onto PHB-MNPs, and the release efficiencies at different pHs were studied under in vitro conditions. The most efficient drug loading concentration was found about 87% at room temperature in phosphate-buffered saline (pH 7.2). The drug-loaded MNPs were stable up to 2 months in neutral pH for mimicking physiological conditions. The drug release studies were performed with acetate buffer (pH 4.5) that mimics endosomal pH. Doxorubicin (60%) released from PHB-MNPs within 65 hours. Doxorubicin-loaded PHB-MNPs were about 2.5-fold more cytotoxic as compared with free drug on resistant Michigan Cancer Foundation-7 (human breast adenocarcinoma, MCF-7) cell line (1 mu M doxorubicin) in vitro. Therefore, doxorubicin-loaded PHB-MNPs lead to overcome the drug resistance. | en_US |
dc.description.sponsorship | Ahi Evran University, Kirsehir, TurkeyAhi Evran University [BAP-PYO-KMY.4001.12.007] | en_US |
dc.description.sponsorship | Supported by Ahi Evran University (BAP-PYO-KMY.4001.12.007), Kirsehir, Turkey. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | en_US |
dc.relation.isversionof | 10.1097/MJT.0000000000000066 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | PHB | en_US |
dc.subject | doxorubicin | en_US |
dc.subject | magnetic nanoparticles | en_US |
dc.subject | targeted drug delivery | en_US |
dc.subject | drug resistance | en_US |
dc.title | Polyhydroxybutyrate-Coated Magnetic Nanoparticles for Doxorubicin Delivery: Cytotoxic Effect Against Doxorubicin-Resistant Breast Cancer Cell Line | en_US |
dc.type | article | en_US |
dc.relation.journal | AMERICAN JOURNAL OF THERAPEUTICS | en_US |
dc.contributor.department | Kırşehir Ahi Evran Üniversitesi, Mühendislik-Mimarlık Fakültesi, Gıda Mühendisliği Bölümü | en_US |
dc.identifier.volume | 21 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.startpage | 453 | en_US |
dc.identifier.endpage | 461 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |